Chapter 14: HPV vaccine introduction in industrialized countries (Q36584361)

15 August 2017

1 reference

title

Chapter 14: HPV vaccine introduction in industrialized countries (English)

1 reference

15 August 2017

0 references

1 reference

2

Pierre Van Damme

1 reference

15 August 2017

3

Heinz-Josef Schmitt

1 reference

15 August 2017

Thomas C Wright

1

1 reference

PubMed ID

16949999

15 August 2017

André Meheus

series ordinal

4

1 reference

PubMed ID

16949999

15 August 2017

language of work or name

English

0 references

publication date

1 August 2006

1 reference

15 August 2017

1 reference

15 August 2017

24 Suppl 3

1 reference

15 August 2017

S3/122-31

1 reference

Childhood vaccine finance and safety issues

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Childhood vaccine purchase costs in the public sector: past trends, future expectations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

The global value of vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Prevention of viral hepatitis in the Nordic countries and Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Prevention of viral hepatitis in Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Compliance of hepatitis B vaccination in patients presenting to a teenage clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Vaccination and perinatal infection prevention practices among obstetrician-gynecologists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Determinants of universal adolescent hepatitis B vaccine uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Factors influencing vaccine uptake in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Factors influencing vaccine uptake in Italy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Child vaccination policies in Europe: a report from the Summits of Independent European Vaccination Experts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Analysis of factors influencing vaccine uptake: perspective from Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Analysis of factors influencing vaccine uptake: perspectives from Belgium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Rubella vaccination in the United States: a ten-year review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

Integration of hepatitis B vaccination into national immunisation programmes. Viral Hepatitis Prevention Board

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.05.118

10.1016/J.VACCINE.2006.05.118

7 January 2021

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16949999